ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fibrinogen Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-29J8897
Home | Market Reports
Global Fibrinogen Market Outlook 2022
BUY CHAPTERS

Global Fibrinogen Market Research Report 2026

Code: QYRE-Auto-29J8897
Report
2026-02-26
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Shanghai RAAS Blood Products
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Taibang Biologic
Octapharma AG
CSL Behring
LFB Group
China Resources Boya Bio-Pharmaceutical
China Meheco Group

Fibrinogen Market Size

The global Fibrinogen market was valued at US$ 1402 million in 2025 and is anticipated to reach US$ 2759 million by 2032, at a CAGR of 10.3% from 2026 to 2032.

Fibrinogen Market

Fibrinogen Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Fibrinogen competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
The market for fibrinogen is primarily driven by the increasing prevalence of bleeding disorders and surgical procedures that require rapid hemostasis, as well as growing awareness and adoption of targeted blood management therapies. Advances in plasma fractionation and recombinant technologies, along with rising demand for safer, pathogen-reduced, and high-purity blood products, are also fueling market growth. Additionally, an aging population, higher incidence of trauma and cardiovascular surgeries, and expansion of healthcare infrastructure in emerging regions contribute to the increasing demand for fibrinogen concentrate.
Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top 1 companies hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.
This report delivers a comprehensive overview of the global Fibrinogen market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Fibrinogen. The Fibrinogen market size, estimates, and forecasts are provided in terms of sales volume (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Fibrinogen market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Fibrinogen manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Fibrinogen Market Report

Report Metric Details
Report Name Fibrinogen Market
Accounted market size in 2025 US$ 1402 million
Forecasted market size in 2032 US$ 2759 million
CAGR 10.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Human Fibrinogen
  • Animal Fibrinogen
by Application
  • Congenital Fibrinogen Deficiency
  • Surgical Procedures
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL Behring, LFB Group, Shanghai RAAS Blood Products, China Resources Boya Bio-pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, China Meheco Group, Taibang Biologic, Octapharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Fibrinogen manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Fibrinogen sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Fibrinogen Market growing?

Ans: The Fibrinogen Market witnessing a CAGR of 10.3% during the forecast period 2026-2032.

What is the Fibrinogen Market size in 2032?

Ans: The Fibrinogen Market size in 2032 will be US$ 2759 million.

What is the market share of major companies in Fibrinogen Market?

Ans: The top 1 companies hold a share about 52%.

What is the Fibrinogen Market share by region?

Ans: North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.

Who are the main players in the Fibrinogen Market report?

Ans: The main players in the Fibrinogen Market are CSL Behring, LFB Group, Shanghai RAAS Blood Products, China Resources Boya Bio-pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, China Meheco Group, Taibang Biologic, Octapharma

What are the Application segmentation covered in the Fibrinogen Market report?

Ans: The Applications covered in the Fibrinogen Market report are Congenital Fibrinogen Deficiency, Surgical Procedures, Others

What are the Type segmentation covered in the Fibrinogen Market report?

Ans: The Types covered in the Fibrinogen Market report are Human Fibrinogen, Animal Fibrinogen

1 Fibrinogen Market Overview
1.1 Product Definition
1.2 Fibrinogen by Type
1.2.1 Global Fibrinogen Market Value by Type: 2025 vs 2032
1.2.2 Human Fibrinogen
1.2.3 Animal Fibrinogen
1.3 Fibrinogen by Application
1.3.1 Global Fibrinogen Market Value by Application: 2025 vs 2032
1.3.2 Congenital Fibrinogen Deficiency
1.3.3 Surgical Procedures
1.3.4 Others
1.4 Global Fibrinogen Market Size Estimates and Forecasts
1.4.1 Global Fibrinogen Revenue 2021–2032
1.4.2 Global Fibrinogen Sales 2021–2032
1.4.3 Global Fibrinogen Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Fibrinogen Market Competition by Manufacturers
2.1 Global Fibrinogen Sales Market Share by Manufacturers (2021–2026)
2.2 Global Fibrinogen Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Fibrinogen Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Fibrinogen, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Fibrinogen, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Fibrinogen, Product Types and Applications
2.7 Global Key Manufacturers of Fibrinogen, Date of Entry into the Industry
2.8 Global Fibrinogen Market Competitive Situation and Trends
2.8.1 Global Fibrinogen Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Fibrinogen Players Market Share by Revenue
2.8.3 Global Fibrinogen Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fibrinogen Market Scenario by Region
3.1 Global Fibrinogen Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Fibrinogen Sales by Region: 2021–2032
3.2.1 Global Fibrinogen Sales by Region: 2021–2026
3.2.2 Global Fibrinogen Sales by Region: 2027–2032
3.3 Global Fibrinogen Revenue by Region: 2021–2032
3.3.1 Global Fibrinogen Revenue by Region: 2021–2026
3.3.2 Global Fibrinogen Revenue by Region: 2027–2032
3.4 North America Fibrinogen Market Facts & Figures by Country
3.4.1 North America Fibrinogen Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Fibrinogen Sales by Country (2021–2032)
3.4.3 North America Fibrinogen Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fibrinogen Market Facts & Figures by Country
3.5.1 Europe Fibrinogen Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Fibrinogen Sales by Country (2021–2032)
3.5.3 Europe Fibrinogen Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fibrinogen Market Facts & Figures by Region
3.6.1 Asia Pacific Fibrinogen Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Fibrinogen Sales by Region (2021–2032)
3.6.3 Asia Pacific Fibrinogen Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fibrinogen Market Facts & Figures by Country
3.7.1 Latin America Fibrinogen Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Fibrinogen Sales by Country (2021–2032)
3.7.3 Latin America Fibrinogen Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fibrinogen Market Facts & Figures by Country
3.8.1 Middle East and Africa Fibrinogen Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Fibrinogen Sales by Country (2021–2032)
3.8.3 Middle East and Africa Fibrinogen Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fibrinogen Sales by Type (2021–2032)
4.1.1 Global Fibrinogen Sales by Type (2021–2026)
4.1.2 Global Fibrinogen Sales by Type (2027–2032)
4.1.3 Global Fibrinogen Sales Market Share by Type (2021–2032)
4.2 Global Fibrinogen Revenue by Type (2021–2032)
4.2.1 Global Fibrinogen Revenue by Type (2021–2026)
4.2.2 Global Fibrinogen Revenue by Type (2027–2032)
4.2.3 Global Fibrinogen Revenue Market Share by Type (2021–2032)
4.3 Global Fibrinogen Price by Type (2021–2032)
5 Segment by Application
5.1 Global Fibrinogen Sales by Application (2021–2032)
5.1.1 Global Fibrinogen Sales by Application (2021–2026)
5.1.2 Global Fibrinogen Sales by Application (2027–2032)
5.1.3 Global Fibrinogen Sales Market Share by Application (2021–2032)
5.2 Global Fibrinogen Revenue by Application (2021–2032)
5.2.1 Global Fibrinogen Revenue by Application (2021–2026)
5.2.2 Global Fibrinogen Revenue by Application (2027–2032)
5.2.3 Global Fibrinogen Revenue Market Share by Application (2021–2032)
5.3 Global Fibrinogen Price by Application (2021–2032)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 CSL Behring Fibrinogen Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 LFB Group
6.2.1 LFB Group Company Information
6.2.2 LFB Group Description and Business Overview
6.2.3 LFB Group Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 LFB Group Fibrinogen Product Portfolio
6.2.5 LFB Group Recent Developments/Updates
6.3 Shanghai RAAS Blood Products
6.3.1 Shanghai RAAS Blood Products Company Information
6.3.2 Shanghai RAAS Blood Products Description and Business Overview
6.3.3 Shanghai RAAS Blood Products Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Shanghai RAAS Blood Products Fibrinogen Product Portfolio
6.3.5 Shanghai RAAS Blood Products Recent Developments/Updates
6.4 China Resources Boya Bio-pharmaceutical
6.4.1 China Resources Boya Bio-pharmaceutical Company Information
6.4.2 China Resources Boya Bio-pharmaceutical Description and Business Overview
6.4.3 China Resources Boya Bio-pharmaceutical Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 China Resources Boya Bio-pharmaceutical Fibrinogen Product Portfolio
6.4.5 China Resources Boya Bio-pharmaceutical Recent Developments/Updates
6.5 Hualan Biological Engineering
6.5.1 Hualan Biological Engineering Company Information
6.5.2 Hualan Biological Engineering Description and Business Overview
6.5.3 Hualan Biological Engineering Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hualan Biological Engineering Fibrinogen Product Portfolio
6.5.5 Hualan Biological Engineering Recent Developments/Updates
6.6 Harbin Pacific Biopharmaceutical
6.6.1 Harbin Pacific Biopharmaceutical Company Information
6.6.2 Harbin Pacific Biopharmaceutical Description and Business Overview
6.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Harbin Pacific Biopharmaceutical Fibrinogen Product Portfolio
6.6.5 Harbin Pacific Biopharmaceutical Recent Developments/Updates
6.7 China Meheco Group
6.7.1 China Meheco Group Company Information
6.7.2 China Meheco Group Description and Business Overview
6.7.3 China Meheco Group Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 China Meheco Group Fibrinogen Product Portfolio
6.7.5 China Meheco Group Recent Developments/Updates
6.8 Taibang Biologic
6.8.1 Taibang Biologic Company Information
6.8.2 Taibang Biologic Description and Business Overview
6.8.3 Taibang Biologic Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Taibang Biologic Fibrinogen Product Portfolio
6.8.5 Taibang Biologic Recent Developments/Updates
6.9 Octapharma
6.9.1 Octapharma Company Information
6.9.2 Octapharma Description and Business Overview
6.9.3 Octapharma Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Octapharma Fibrinogen Product Portfolio
6.9.5 Octapharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fibrinogen Industry Chain Analysis
7.2 Fibrinogen Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fibrinogen Production Mode & Process Analysis
7.4 Fibrinogen Sales and Marketing
7.4.1 Fibrinogen Sales Channels
7.4.2 Fibrinogen Distributors
7.5 Fibrinogen Customer Analysis
8 Fibrinogen Market Dynamics
8.1 Fibrinogen Industry Trends
8.2 Fibrinogen Market Drivers
8.3 Fibrinogen Market Challenges
8.4 Fibrinogen Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Shanghai RAAS Blood Products
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Taibang Biologic
Octapharma AG
CSL Behring
LFB Group
China Resources Boya Bio-Pharmaceutical
China Meheco Group
List of Tables
 Table 1. Global Fibrinogen Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Fibrinogen Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Fibrinogen Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Fibrinogen Sales (Kg) of Key Manufacturers (2021–2026)
 Table 5. Global Fibrinogen Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Fibrinogen Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Fibrinogen Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Fibrinogen Average Price (US$/g) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Fibrinogen, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Fibrinogen, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Fibrinogen, Product Types and Applications
 Table 12. Global Key Manufacturers of Fibrinogen, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Fibrinogen Companies by Tier (Tier 1, Tier 2, Tier 3), based on Fibrinogen Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Fibrinogen Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Fibrinogen Sales by Region (Kg), 2021–2026
 Table 18. Global Fibrinogen Sales Market Share by Region (2021–2026)
 Table 19. Global Fibrinogen Sales by Region (Kg), 2027–2032
 Table 20. Global Fibrinogen Sales Market Share by Region (2027–2032)
 Table 21. Global Fibrinogen Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Fibrinogen Revenue Market Share by Region (2021–2026)
 Table 23. Global Fibrinogen Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Fibrinogen Revenue Market Share by Region (2027–2032)
 Table 25. North America Fibrinogen Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Fibrinogen Sales by Country (Kg), 2021–2026
 Table 27. North America Fibrinogen Sales by Country (Kg), 2027–2032
 Table 28. North America Fibrinogen Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Fibrinogen Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Fibrinogen Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Fibrinogen Sales by Country (Kg), 2021–2026
 Table 32. Europe Fibrinogen Sales by Country (Kg), 2027–2032
 Table 33. Europe Fibrinogen Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Fibrinogen Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Fibrinogen Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Fibrinogen Sales by Region (Kg), 2021–2026
 Table 37. Asia Pacific Fibrinogen Sales by Region (Kg), 2027–2032
 Table 38. Asia Pacific Fibrinogen Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Fibrinogen Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Fibrinogen Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Fibrinogen Sales by Country (Kg), 2021–2026
 Table 42. Latin America Fibrinogen Sales by Country (Kg), 2027–2032
 Table 43. Latin America Fibrinogen Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Fibrinogen Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Fibrinogen Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Fibrinogen Sales by Country (Kg), 2021–2026
 Table 47. Middle East and Africa Fibrinogen Sales by Country (Kg), 2027–2032
 Table 48. Middle East and Africa Fibrinogen Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Fibrinogen Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Fibrinogen Sales (Kg) by Type (2021–2026)
 Table 51. Global Fibrinogen Sales (Kg) by Type (2027–2032)
 Table 52. Global Fibrinogen Sales Market Share by Type (2021–2026)
 Table 53. Global Fibrinogen Sales Market Share by Type (2027–2032)
 Table 54. Global Fibrinogen Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Fibrinogen Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Fibrinogen Revenue Market Share by Type (2021–2026)
 Table 57. Global Fibrinogen Revenue Market Share by Type (2027–2032)
 Table 58. Global Fibrinogen Price (US$/g) by Type (2021–2026)
 Table 59. Global Fibrinogen Price (US$/g) by Type (2027–2032)
 Table 60. Global Fibrinogen Sales (Kg) by Application (2021–2026)
 Table 61. Global Fibrinogen Sales (Kg) by Application (2027–2032)
 Table 62. Global Fibrinogen Sales Market Share by Application (2021–2026)
 Table 63. Global Fibrinogen Sales Market Share by Application (2027–2032)
 Table 64. Global Fibrinogen Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Fibrinogen Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Fibrinogen Revenue Market Share by Application (2021–2026)
 Table 67. Global Fibrinogen Revenue Market Share by Application (2027–2032)
 Table 68. Global Fibrinogen Price (US$/g) by Application (2021–2026)
 Table 69. Global Fibrinogen Price (US$/g) by Application (2027–2032)
 Table 70. CSL Behring Company Information
 Table 71. CSL Behring Description and Business Overview
 Table 72. CSL Behring Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 73. CSL Behring Fibrinogen Product
 Table 74. CSL Behring Recent Developments/Updates
 Table 75. LFB Group Company Information
 Table 76. LFB Group Description and Business Overview
 Table 77. LFB Group Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 78. LFB Group Fibrinogen Product
 Table 79. LFB Group Recent Developments/Updates
 Table 80. Shanghai RAAS Blood Products Company Information
 Table 81. Shanghai RAAS Blood Products Description and Business Overview
 Table 82. Shanghai RAAS Blood Products Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 83. Shanghai RAAS Blood Products Fibrinogen Product
 Table 84. Shanghai RAAS Blood Products Recent Developments/Updates
 Table 85. China Resources Boya Bio-pharmaceutical Company Information
 Table 86. China Resources Boya Bio-pharmaceutical Description and Business Overview
 Table 87. China Resources Boya Bio-pharmaceutical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 88. China Resources Boya Bio-pharmaceutical Fibrinogen Product
 Table 89. China Resources Boya Bio-pharmaceutical Recent Developments/Updates
 Table 90. Hualan Biological Engineering Company Information
 Table 91. Hualan Biological Engineering Description and Business Overview
 Table 92. Hualan Biological Engineering Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 93. Hualan Biological Engineering Fibrinogen Product
 Table 94. Hualan Biological Engineering Recent Developments/Updates
 Table 95. Harbin Pacific Biopharmaceutical Company Information
 Table 96. Harbin Pacific Biopharmaceutical Description and Business Overview
 Table 97. Harbin Pacific Biopharmaceutical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 98. Harbin Pacific Biopharmaceutical Fibrinogen Product
 Table 99. Harbin Pacific Biopharmaceutical Recent Developments/Updates
 Table 100. China Meheco Group Company Information
 Table 101. China Meheco Group Description and Business Overview
 Table 102. China Meheco Group Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 103. China Meheco Group Fibrinogen Product
 Table 104. China Meheco Group Recent Developments/Updates
 Table 105. Taibang Biologic Company Information
 Table 106. Taibang Biologic Description and Business Overview
 Table 107. Taibang Biologic Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 108. Taibang Biologic Fibrinogen Product
 Table 109. Taibang Biologic Recent Developments/Updates
 Table 110. Octapharma Company Information
 Table 111. Octapharma Description and Business Overview
 Table 112. Octapharma Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 113. Octapharma Fibrinogen Product
 Table 114. Octapharma Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Fibrinogen Distributors List
 Table 118. Fibrinogen Customers List
 Table 119. Fibrinogen Market Trends
 Table 120. Fibrinogen Market Drivers
 Table 121. Fibrinogen Market Challenges
 Table 122. Fibrinogen Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Fibrinogen
 Figure 2. Global Fibrinogen Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Fibrinogen Market Share by Type: 2025 & 2032
 Figure 4. Human Fibrinogen Product Picture
 Figure 5. Animal Fibrinogen Product Picture
 Figure 6. Global Fibrinogen Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Fibrinogen Market Share by Application: 2025 & 2032
 Figure 8. Congenital Fibrinogen Deficiency
 Figure 9. Surgical Procedures
 Figure 10. Others
 Figure 11. Global Fibrinogen Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Fibrinogen Market Size (US$ Million), 2021–2032
 Figure 13. Global Fibrinogen Sales (Kg), 2021–2032
 Figure 14. Global Fibrinogen Average Price (US$/g), 2021–2032
 Figure 15. Fibrinogen Report Years Considered
 Figure 16. Fibrinogen Sales Share by Manufacturers in 2025
 Figure 17. Global Fibrinogen Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Fibrinogen Players: Market Share by Revenue in Fibrinogen in 2025
 Figure 19. Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Fibrinogen Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Fibrinogen Sales Market Share by Country (2021–2032)
 Figure 22. North America Fibrinogen Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Fibrinogen Sales Market Share by Country (2021–2032)
 Figure 26. Europe Fibrinogen Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Fibrinogen Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Fibrinogen Revenue Market Share by Region (2021–2032)
 Figure 34. China Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Taiwan Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Fibrinogen Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Fibrinogen Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Fibrinogen Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Fibrinogen Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Fibrinogen by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Fibrinogen by Type (2021–2032)
 Figure 56. Global Fibrinogen Price (US$/g) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Fibrinogen by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Fibrinogen by Application (2021–2032)
 Figure 59. Global Fibrinogen Price (US$/g) by Application (2021–2032)
 Figure 60. Fibrinogen Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Human Fibrinogen Market Insights Forecast to 2030
Animal Fibrinogen Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrinogen Concentrate Market Research Report 2025
Global Coagulation Factor Concentrate Market Research Report 2025
Human Fibrinogen Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrinogen Reagent Kits Market Insights Forecast to 2030
Global Fibrinogen Testing Reagents Market Insights Forecast to 2030
Global Recombinant Coagulation Factor Concentrate Market Research Report 2024
Human Fibrin Glue Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrin Specific Drugs Market Research Report 2024
Clotting Factor Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrin Glue Hemostat Market Research Report 2024
Global Plasma Protein Products Market Research Report 2024
Fibrin Medical Adhesive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Coagulation Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrin Sealant Product Market Research Report 2024
Blood Coagulation Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Clotting Factor Market Research Report 2025
Global Fibrinogen Deficiency Drug Market Research Report 2025
Global Human Blood Products Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions